Pfizer beats earnings estimates as declining Covid business performs better than expected
[ad_1] Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a
Read More
Pharmaceuticals
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
[ad_1] Sen. Bernie Sanders, I-Vt., holds his news conference with Sen. Ed Markey, D-Mass., in the Capitol on Thursday, January
Read More
Humana stock plunges on dismal 2024 forecast, as insurers face soaring medical costs
[ad_1] Signage is displayed on a Humana Inc. office building in Louisville, Kentucky, U.S., on Sunday, Feb. 3, 2019. Humana
Read More
Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million
[ad_1] In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in
Read More
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
[ad_1] Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture
Read More
Bristol-Myers CEO talks new acquisitions: 'We are writing the next chapter of this company'
[ad_1] Bristol-Myers Squibb CEO Chris Boerner detailed the pharmaceutical giant’s bundle of recent acquisitions in a Monday interview with CNBC’s
Read More
Eli Lilly's direct drug sales alone may not upend the industry, but others could follow suit
[ad_1] Sopa Images | Lightrocket | Getty Images Eli Lilly is shaking up the pharmaceutical industry with a new website
Read More
Florida wins first FDA approval to import cheaper drugs from Canada
[ad_1] Pharmacist Thomas Jensen looks over a prescription drug at the Rock Canyon Pharmacy in Provo, Utah, on May 9,
Read More
Walgreens posts earnings beat but slashes quarterly dividend nearly in half
[ad_1] A man walks near a Walgreens pharmacy on March 09, 2023 in New York City. Leonardo Munoz | Corbis
Read More
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
[ad_1] Artur Widak | Nurphoto | Getty Images Shares of Moderna closed more than 13% higher on Tuesday after Oppenheimer
Read More